| Literature DB >> 33905568 |
Jonathan J Rios1,2,3,4,5, Bruce Beutler6, Kristin Denton1, Jamie Russell6, Julia Kozlitina3, Carlos R Ferreira7, Amy F Lewanda8, Joshua E Mayfield9, Eva Moresco6, Sara Ludwig6, Miao Tang6, Xiaohong Li6, Stephen Lyon6, Anas Khanshour1, Nandina Paria1, Aysha Khalid1, Yang Li1, Xudong Xie10, Jian Q Feng10, Qian Xu10, Yongbo Lu10, Robert E Hammer11, Carol A Wise1,2,3,4.
Abstract
Proper embryonic and postnatal skeletal development require coordination of myriad complex molecular mechanisms. Disruption of these processes, through genetic mutation, contributes to variation in skeletal development. We developed a high-throughput N-ethyl-N-nitrosourea (ENU)-induced saturation mutagenesis skeletal screening approach in mice to identify genes required for proper skeletal development. Here, we report initial results from live-animal X-ray and dual-energy X-ray absorptiometry (DXA) imaging of 27,607 G3 mice from 806 pedigrees, testing the effects of 32,198 coding/splicing mutations in 13,020 genes. A total of 39.7% of all autosomal genes were severely damaged or destroyed by mutations tested twice or more in the homozygous state. Results from our study demonstrate the feasibility of in vivo mutagenesis to identify mouse models of skeletal disease. Furthermore, our study demonstrates how ENU mutagenesis provides opportunities to create and characterize putative hypomorphic mutations in developmentally essential genes. Finally, we present a viable mouse model and case report of recessive skeletal disease caused by mutations in FAM20B. Results from this study, including engineered mouse models, are made publicly available via the online Mutagenetix database.Entities:
Keywords: DXA; GENETIC ANIMAL MODELS; MOLECULAR PATHWAYS-DEVELOPMENT; OSTEOBLASTS; WNT/B-CATENIN/LRPs
Mesh:
Substances:
Year: 2021 PMID: 33905568 PMCID: PMC8862308 DOI: 10.1002/jbmr.4323
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.390